Position in BOLT
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$120,524
-$5,948 QoQ
Shares Held
31,305
0.0% QoQ
Ownership
1.63%
of shares outstanding
% of Portfolio
0.07%
of 13F equity value
Holder Rank
#7
of 23 holders
Holding Since
Jun 2025
5 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in BOLT Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Pfizer Inc holds $174,727,373 across 16 Biotechnology names. BOLT ranks #14 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ALLO |
Allogene Therapeutics, Inc.
|
22,032,040 | $45,826,643 | |
| 2 | CELC |
Celcuity Inc.
|
295,652 | $30,931,112 | |
| 3 | ARVN |
Arvinas, Inc.
|
3,457,815 | $28,734,442 | |
| 4 | PYXS |
Pyxis Oncology, Inc.
|
7,032,770 | $21,168,637 | |
| 5 | WVE |
Wave Life Sciences, Inc.
|
1,875,000 | $10,893,750 | |
| 6 | CRBU |
Caribou Biosciences, Inc.
|
4,690,431 | $8,255,158 | |
| 7 | BHVN |
Biohaven Ltd.
|
505,645 | $7,523,997 | |
| 8 | SPRO |
Spero Therapeutics, Inc.
|
2,362,348 | $5,220,789 |
All Filings in BOLT
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $120,524 | 31,305 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $126,472 | 31,305 | Shares | Defined | 2026-05-12 | |
| 2025-12-31 | $171,175 | 31,305 | Shares | Defined | 2026-02-12 | |
| 2025-09-30 | $166,542 | 31,305 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $180,629 | 31,305 | Shares | Defined | 2025-08-11 | |
| No filing history on record for this holder in this stock. | ||||||